Atopobiosis and Dysbiosis in Ocular Diseases: Is Fecal Microbiota Transplant and Probiotics a Promising Solution?

Abstract Purpose: To highlight the role of atopobiosis and dysbiosis in the pathomechanism of autoimmune uveitis, therefore supporting fecal microbiota transplant (FMT) and probiotics as potential targeted-treatment for uveitis. Methods: This review synthesized literatures upon the relation between...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Triana Hardianti Gunardi, Diannisa Paramita Susantono, Andi Arus Victor, Ratna Sitompul
Formato: article
Lenguaje:EN
Publicado: Knowledge E 2021
Materias:
Acceso en línea:https://doaj.org/article/7df08bdc57ae41f78831a7644d601b65
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7df08bdc57ae41f78831a7644d601b65
record_format dspace
spelling oai:doaj.org-article:7df08bdc57ae41f78831a7644d601b652021-11-09T08:05:35ZAtopobiosis and Dysbiosis in Ocular Diseases: Is Fecal Microbiota Transplant and Probiotics a Promising Solution?2008-20102008-322X10.18502/jovr.v16i4.9754https://doaj.org/article/7df08bdc57ae41f78831a7644d601b652021-10-01T00:00:00Zhttps://doi.org/10.18502/jovr.v16i4.9754https://doaj.org/toc/2008-2010https://doaj.org/toc/2008-322XAbstract Purpose: To highlight the role of atopobiosis and dysbiosis in the pathomechanism of autoimmune uveitis, therefore supporting fecal microbiota transplant (FMT) and probiotics as potential targeted-treatment for uveitis. Methods: This review synthesized literatures upon the relation between gut microbiota, autoimmune uveitis, FMT, and probiotics, published from January 2001 to March 2021 and indexed in PubMed, Google Scholar, CrossRef. Results: The basis of the gut–eye axis revolves around occurrences of molecular mimicry, increase in pro-inflammatory cytokines, gut epithelial barrier disruption, and translocation of microbes to distant sites. In patients with autoimmune uveitis, an increase of gut Fusobacterium and Enterobacterium were found. With current knowledge of aforementioned mechanisms, studies modifying the gut microbiome and restoring the physiologic gut barrier has been the main focus for pathomechanism-based therapy. In mice models, FMT and probiotics targeting repopulation of gut microbiota has shown significant improvement in clinical manifestations of uveitis. Consequently, a better understanding in the homeostasis of gut microbiome along with their role in the gut–eye axis is needed to develop practical targeted treatment. Conclusion: Current preliminary studies are promising in establishing a causative gut–eye axis relationship and the possibility of conducting FMT and probiotics as targeted treatment to mitigate autoimmune uveitis, to shorten disease duration, and to prevent further complications.Triana Hardianti GunardiDiannisa Paramita SusantonoAndi Arus VictorRatna SitompulKnowledge Earticleatopobiosisautoimmunedysbiosisgut–eye axisuveitisOphthalmologyRE1-994ENJournal of Ophthalmic & Vision Research, Vol 16, Iss 4, Pp 631-643 (2021)
institution DOAJ
collection DOAJ
language EN
topic atopobiosis
autoimmune
dysbiosis
gut–eye axis
uveitis
Ophthalmology
RE1-994
spellingShingle atopobiosis
autoimmune
dysbiosis
gut–eye axis
uveitis
Ophthalmology
RE1-994
Triana Hardianti Gunardi
Diannisa Paramita Susantono
Andi Arus Victor
Ratna Sitompul
Atopobiosis and Dysbiosis in Ocular Diseases: Is Fecal Microbiota Transplant and Probiotics a Promising Solution?
description Abstract Purpose: To highlight the role of atopobiosis and dysbiosis in the pathomechanism of autoimmune uveitis, therefore supporting fecal microbiota transplant (FMT) and probiotics as potential targeted-treatment for uveitis. Methods: This review synthesized literatures upon the relation between gut microbiota, autoimmune uveitis, FMT, and probiotics, published from January 2001 to March 2021 and indexed in PubMed, Google Scholar, CrossRef. Results: The basis of the gut–eye axis revolves around occurrences of molecular mimicry, increase in pro-inflammatory cytokines, gut epithelial barrier disruption, and translocation of microbes to distant sites. In patients with autoimmune uveitis, an increase of gut Fusobacterium and Enterobacterium were found. With current knowledge of aforementioned mechanisms, studies modifying the gut microbiome and restoring the physiologic gut barrier has been the main focus for pathomechanism-based therapy. In mice models, FMT and probiotics targeting repopulation of gut microbiota has shown significant improvement in clinical manifestations of uveitis. Consequently, a better understanding in the homeostasis of gut microbiome along with their role in the gut–eye axis is needed to develop practical targeted treatment. Conclusion: Current preliminary studies are promising in establishing a causative gut–eye axis relationship and the possibility of conducting FMT and probiotics as targeted treatment to mitigate autoimmune uveitis, to shorten disease duration, and to prevent further complications.
format article
author Triana Hardianti Gunardi
Diannisa Paramita Susantono
Andi Arus Victor
Ratna Sitompul
author_facet Triana Hardianti Gunardi
Diannisa Paramita Susantono
Andi Arus Victor
Ratna Sitompul
author_sort Triana Hardianti Gunardi
title Atopobiosis and Dysbiosis in Ocular Diseases: Is Fecal Microbiota Transplant and Probiotics a Promising Solution?
title_short Atopobiosis and Dysbiosis in Ocular Diseases: Is Fecal Microbiota Transplant and Probiotics a Promising Solution?
title_full Atopobiosis and Dysbiosis in Ocular Diseases: Is Fecal Microbiota Transplant and Probiotics a Promising Solution?
title_fullStr Atopobiosis and Dysbiosis in Ocular Diseases: Is Fecal Microbiota Transplant and Probiotics a Promising Solution?
title_full_unstemmed Atopobiosis and Dysbiosis in Ocular Diseases: Is Fecal Microbiota Transplant and Probiotics a Promising Solution?
title_sort atopobiosis and dysbiosis in ocular diseases: is fecal microbiota transplant and probiotics a promising solution?
publisher Knowledge E
publishDate 2021
url https://doaj.org/article/7df08bdc57ae41f78831a7644d601b65
work_keys_str_mv AT trianahardiantigunardi atopobiosisanddysbiosisinoculardiseasesisfecalmicrobiotatransplantandprobioticsapromisingsolution
AT diannisaparamitasusantono atopobiosisanddysbiosisinoculardiseasesisfecalmicrobiotatransplantandprobioticsapromisingsolution
AT andiarusvictor atopobiosisanddysbiosisinoculardiseasesisfecalmicrobiotatransplantandprobioticsapromisingsolution
AT ratnasitompul atopobiosisanddysbiosisinoculardiseasesisfecalmicrobiotatransplantandprobioticsapromisingsolution
_version_ 1718441212731457536